JP2025506335A - サリチル酸組成物およびその使用 - Google Patents

サリチル酸組成物およびその使用 Download PDF

Info

Publication number
JP2025506335A
JP2025506335A JP2024541088A JP2024541088A JP2025506335A JP 2025506335 A JP2025506335 A JP 2025506335A JP 2024541088 A JP2024541088 A JP 2024541088A JP 2024541088 A JP2024541088 A JP 2024541088A JP 2025506335 A JP2025506335 A JP 2025506335A
Authority
JP
Japan
Prior art keywords
metabolite
salicylic acid
extract
formulation
urinary tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541088A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506335A5 (https=
Inventor
メウーリ，フィリップ
ポッタラット，オリビエ
シュナイダー，ブルーノ
Original Assignee
ファーマルプ エスエー
ウニベルジテート バーゼル
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファーマルプ エスエー, ウニベルジテート バーゼル filed Critical ファーマルプ エスエー
Publication of JP2025506335A publication Critical patent/JP2025506335A/ja
Publication of JP2025506335A5 publication Critical patent/JP2025506335A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024541088A 2022-02-22 2023-02-22 サリチル酸組成物およびその使用 Pending JP2025506335A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158048 2022-02-22
EP22158048.3 2022-02-22
PCT/EP2023/054364 WO2023161247A1 (en) 2022-02-22 2023-02-22 Salicylic acid compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2025506335A true JP2025506335A (ja) 2025-03-11
JP2025506335A5 JP2025506335A5 (https=) 2026-02-17

Family

ID=80447273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541088A Pending JP2025506335A (ja) 2022-02-22 2023-02-22 サリチル酸組成物およびその使用

Country Status (8)

Country Link
US (1) US20250152609A1 (https=)
EP (1) EP4482580A1 (https=)
JP (1) JP2025506335A (https=)
CN (1) CN118871117A (https=)
AU (1) AU2023224336A1 (https=)
CA (1) CA3261158A1 (https=)
MX (1) MX2024009823A (https=)
WO (1) WO2023161247A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123356B2 (en) * 2017-03-09 2021-09-21 Epilobium, Inc. Methods of use for oenothein A and B from Epilobium species
US11400102B2 (en) * 2019-05-23 2022-08-02 Washington University Treatment for bacterial infections with salicylic acid analogs

Also Published As

Publication number Publication date
CN118871117A (zh) 2024-10-29
CA3261158A1 (en) 2023-08-31
AU2023224336A1 (en) 2024-07-25
US20250152609A1 (en) 2025-05-15
EP4482580A1 (en) 2025-01-01
MX2024009823A (es) 2024-08-20
WO2023161247A1 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
EP2624702B1 (en) Anti-biofilm compositions and methods for using
JP6226459B2 (ja) Ｆｒａｘｉｎｕｓｅｘｃｅｌｓｉｏｒ種子の抽出物とその治療適用
US6979471B1 (en) Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra
US10391134B2 (en) Anti-candida compositions and uses thereof
Shi et al. Cranberry (Vacinium macrocarpon) phytochemicals inhibit hepatic stellate cell activation and liver fibrosis
CN110300616A (zh) 用于治疗泌尿生殖器官的病症的组合物
Obuotor et al. Antimicrobial activity of Sida acuta, Phyllanthus amarus and Phyllanthus muellerianus against microorganisms implicated in urinary tract infections
CN110300593B (zh) 用于咳嗽的组合物
EP2040692B1 (de) Medizinische verwendung von n-phenylpropenoyl-aminosäurederivaten
JP2025506335A (ja) サリチル酸組成物およびその使用
JP2007524666A (ja) リグナン系化合物を利用したニキビ治療方法及び組成物（ｍｅｔｈｏｄａｎｄｃｏｍｐｏｓｉｔｉｏｎｆｏｒｔｒｅａｔｉｎｇａｃｎｅｕｓｉｎｇｌｉｇｎａｎｃｏｍｐｏｕｎｄｓ）
Tchoumba Tchoumi et al. Antimicrobial and antidiarrhoeal activities of aqueous and methanolic extracts of Mangifera indica Linn stem bark (Anarcadiaceae) in Wistar rats: LMT Tchoumi et al.
Owolabi et al. In vitro antimicrobial appraisal of the potentials of Morinda lucida against some selected bacteria
Pandurangan et al. Evaluation of anti-inflammatory activity of Bryophyllum calycinum (Crassulaceae) on acute and chronic inflammation models
Aruljothi et al. Antibacterial and antifungal activity of leaf extracts of Pedalium murex L
JP2004083581A (ja) 尿路感染症の治療剤
Noumedem et al. Antibacterial, antioxydant and antidiarrheal properties of Tristemma hirtum P. beauv
CN103889431B (zh) 开联番木鳖苷酸、包含其的药物组合物及其用途
WO2002017939A1 (en) A composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from glycyrrhiza glabra
Rashid et al. A PROMISING ANTIDIARRHOEAL, ANTIMICROBIAL AND ANTHELMINTIC EFFECT OF METHANOLIC EXTRACT OF HYGRORYZA ARISTATA LEAVES
KR20250082078A (ko) 미역쇠 추출물을 포함하는 폐건강 개선 활성을 갖는 조성물
HK40011961A (en) Composition for use in the treatment of disorders of the urogenital apparatus
POTHURAJU ANIMAL BIOCHEMISTRY
HK1195487A (en) Method for producing dry extracts
JP2013526553A (ja) 婦人科疾患の治療用組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240724

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260206